Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiwoong Lim

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Nature Communications|July 2, 2024
In silico fragment-based discovery of CIB1-directed anti-tumor agents by FRASE-botYi An, Jiwoong Lim, Marta Glavatskikh, et al.
Research Square|August 30, 2023
Machine Learning-driven Fragment-based Discovery of CIB1-directed Anti-Tumor Agents by FRASE-botYi An, Marta Glavatskikh, Jiwoong Lim, et al.
Organic Letters|August 1, 2024
Structural Modification and Characteristics of Lappaconitine Alkaloid for the Discovery of Bioactive Components by Hypervalent Iodine ReagentChang Sang Moon, Heung Mo Kang, Yunchan Nam, et al.
Journal of Medicinal Chemistry|September 12, 2025
Development of Next Generation Cell-Permeable Peptide Inhibitors for the Oncological Target MAGE-A4Jiwoong Lim, Lilly F Chiou, Brandon Novy, et al.
Journal of Medicinal Chemistry|May 6, 2022
Discovery and Structural Basis of the Selectivity of Potent Cyclic Peptide Inhibitors of MAGE-A4Matthew C Fleming, Lilly F Chiou, Percy P Tumbale, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Nature Communications|July 2, 2024
In silico fragment-based discovery of CIB1-directed anti-tumor agents by FRASE-botYi An, Jiwoong Lim, Marta Glavatskikh, et al.
Research Square|August 30, 2023
Machine Learning-driven Fragment-based Discovery of CIB1-directed Anti-Tumor Agents by FRASE-botYi An, Marta Glavatskikh, Jiwoong Lim, et al.
Organic Letters|August 1, 2024
Structural Modification and Characteristics of Lappaconitine Alkaloid for the Discovery of Bioactive Components by Hypervalent Iodine ReagentChang Sang Moon, Heung Mo Kang, Yunchan Nam, et al.
Journal of Medicinal Chemistry|September 12, 2025
Development of Next Generation Cell-Permeable Peptide Inhibitors for the Oncological Target MAGE-A4Jiwoong Lim, Lilly F Chiou, Brandon Novy, et al.
Journal of Medicinal Chemistry|May 6, 2022
Discovery and Structural Basis of the Selectivity of Potent Cyclic Peptide Inhibitors of MAGE-A4Matthew C Fleming, Lilly F Chiou, Percy P Tumbale, et al.
Pageof 1